A Study to Evaluate the Bioavailability of Two Specifications of Oral Deuremidevir Hydrobromide for Suspension

NCT06749236 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Participants

Interventions

DRUG: test formulation(T) 200 mg deuteriumremidvir hydrobromide for suspension
DRUG: reference formulation(R) 100 mg deuteriumremidvir hydrobromide for suspension

Sponsor

Vigonvita Life Sciences